http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2745651-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d584042a524740a406723fe1631e49e5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02 |
| filingDate | 2020-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26a63ae887f023887613236b88ec5880 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faa89978122cd9d4ed211b29f66f328a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba02a30c4357568d9cb52844d072f8e2 |
| publicationDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2745651-C1 |
| titleOfInvention | Method for the prevention of the "no-reflow" phenomenon during percutaneous coronary interventions in patients with acute myocardial infarction with st segment evalution |
| abstract | FIELD: cardiology.SUBSTANCE: 0.014-inch coronary guidewire is passed to the distal infarction-dependent artery. Control angiography is performed. When contrasting the area of the artery located distal to the site of its target lesion, direct agency is performed. In the absence of contrasting of the infarct-dependent artery distal to the site of the target lesion, a balloon catheter is brought along the coronary conductor to the site of occlusion onset. Then, without inflating it, a three-fold reciprocating movement of the unopened balloon catheter is performed through the occlusion site at a distance of 30 mm distal to the initial position and back. After that, control contrasting and direct stenting of the target lesion of the infarct-dependent artery are performed.EFFECT: method allows reducing the risk of developing hemorrhagic complications, preventing the development of the phenomenon of "no-reflow" infarction-related coronary artery in patients with AMI when performing percutaneous coronary interventions.1 cl, 12 dwg, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2786150-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2798161-C1 |
| priorityDate | 2020-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.